The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackmore, T. K.
Right arrow Articles by Gordon, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackmore, T. K.
Right arrow Articles by Gordon, D. L.
The Journal of Immunology, 1998, 160: 3342-3348.
Copyright © 1998 by The American Association of Immunologists

Identification of the Second Heparin-Binding Domain in Human Complement Factor H1

Timothy K. Blackmore2,*, Jens Hellwage{dagger}, Tania A. Sadlon*, Naomi Higgs*, Peter F. Zipfel{dagger}, Helena M. Ward* and David L. Gordon*

* Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, South Australia, Australia; and {dagger} Department of Molecular Biology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces. Heparin binding has been used as a model for examining the sialic acid-binding characteristics of fH. We have previously shown that of the 20 short consensus repeat (SCR) modules of fH, SCR 7 contains an important heparin binding site, but other SCRs also play a role in heparin binding. To localize the other sites, we prepared recombinant truncated and SCR deletion mutants of fH and tested them by heparin-agarose affinity chromatography. The 5 C-terminal SCRs were found to contain a heparin binding site as an SCR 7 deletion mutant of the N terminal 15 SCRs did not bind heparin, but a construct consisting of SCRs 16–20 was shown to bind heparin. Double deletion of SCRs 7 and 20 from fH abrogated binding to heparin, indicating that SCR 20 contains a heparin binding site. This finding was confirmed with the observation that attachment of SCR 20 to a group of nonbinding SCRs produced a heparin-binding protein. A protein consisting of SCRs 19 and 20 did not bind heparin, whereas SCRs 18–20 did, indicating that, although SCR 20 contains a heparin binding site, at least two nonspecific adjacent SCRs are required. fH-related protein-3 (FHR-3) possesses an SCR homologous to SCR 7 of fH and bound heparin, whereas FHR-4, which lacks such an SCR, did not. Thus, fH contains two separate heparin binding sites, which are located in SCRs 7 and 20.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. Biedzka-Sarek, H. Jarva, H. Hyytiainen, S. Meri, and M. Skurnik
Characterization of Complement Factor H Binding to Yersinia enterocolitica Serotype O:3
Infect. Immun., September 1, 2008; 76(9): 4100 - 4109.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Q. Schmidt, A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton, B. S. Blaum, M. Lyon, D. Uhrin, and P. N. Barlow
A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H
J. Immunol., August 15, 2008; 181(4): 2610 - 2619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Hallstrom, P. F. Zipfel, A. M. Blom, N. Lauer, A. Forsgren, and K. Riesbeck
Haemophilus influenzae Interacts with the Human Complement Inhibitor Factor H
J. Immunol., July 1, 2008; 181(1): 537 - 545.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A.-l. Stahl, F. Vaziri-Sani, S. Heinen, A.-C. Kristoffersson, K.-H. Gydell, R. Raafat, A. Gutierrez, O. Beringer, P. F. Zipfel, and D. Karpman
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
Blood, June 1, 2008; 111(11): 5307 - 5315.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. J. Ormsby, S. Ranganathan, J. C. Tong, K. M. Griggs, D. P. Dimasi, A. W. Hewitt, K. P. Burdon, J. E. Craig, J. Hoh, and D. L. Gordon
Functional and Structural Implications of the Complement Factor H Y402H Polymorphism Associated with Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1763 - 1770.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. G. Hocking, A. P. Herbert, D. Kavanagh, D. C. Soares, V. P. Ferreira, M. K. Pangburn, D. Uhrin, and P. N. Barlow
Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations
J. Biol. Chem., April 4, 2008; 283(14): 9475 - 9487.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. E. Prosser, S. Johnson, P. Roversi, A. P. Herbert, B. S. Blaum, J. Tyrrell, T. A. Jowitt, S. J. Clark, E. Tarelli, D. Uhrin, et al.
Structural basis for complement factor H linked age-related macular degeneration
J. Exp. Med., October 1, 2007; 204(10): 2277 - 2283.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Herbert, J. A. Deakin, C. Q. Schmidt, B. S. Blaum, C. Egan, V. P. Ferreira, M. K. Pangburn, M. Lyon, D. Uhrin, and P. N. Barlow
Structure Shows That a Glycosaminoglycan and Protein Recognition Site in Factor H Is Perturbed by Age-related Macular Degeneration-linked Single Nucleotide Polymorphism
J. Biol. Chem., June 29, 2007; 282(26): 18960 - 18968.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. Findlow, A. Holland, D. Martin, P. Oster, P. Balmer, and R. Borrow
Inadequacy of Colominic Acid as an Absorbent Intended To Facilitate Use of Complement-Preserved Baby Rabbit Serum in the Neisseria meningitidis Serogroup B Serum Bactericidal Antibody Assay
Clin. Vaccine Immunol., May 1, 2007; 14(5): 556 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. P. Ferreira, A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn
Critical Role of the C-Terminal Domains of Factor H in Regulating Complement Activation at Cell Surfaces
J. Immunol., November 1, 2006; 177(9): 6308 - 6316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Clark, V. A. Higman, B. Mulloy, S. J. Perkins, S. M. Lea, R. B. Sim, and A. J. Day
His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form
J. Biol. Chem., August 25, 2006; 281(34): 24713 - 24720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Herbert, D. Uhrin, M. Lyon, M. K. Pangburn, and P. N. Barlow
Disease-associated Sequence Variations Congregate in a Polyanion Recognition Patch on Human Factor H Revealed in Three-dimensional Structure
J. Biol. Chem., June 16, 2006; 281(24): 16512 - 16520.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Thurman and V. M. Holers
The Central Role of the Alternative Complement Pathway in Human Disease
J. Immunol., February 1, 2006; 176(3): 1305 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Jozsi, S. Heinen, A. Hartmann, C. W. Ostrowicz, S. Halbich, H. Richter, A. Kunert, C. Licht, R. E. Saunders, S. J. Perkins, et al.
Factor H and Atypical Hemolytic Uremic Syndrome: Mutations in the C-Terminus Cause Structural Changes and Defective Recognition Functions
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 170 - 177.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. S. Jokiranta, Z.-Z. Cheng, H. Seeberger, M. Jozsi, S. Heinen, M. Noris, G. Remuzzi, R. Ormsby, D. L. Gordon, S. Meri, et al.
Binding of Complement Factor H to Endothelial Cells Is Mediated by the Carboxy-Terminal Glycosaminoglycan Binding Site
Am. J. Pathol., October 1, 2005; 167(4): 1173 - 1181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. McRae, T. G. Duthy, K. M. Griggs, R. J. Ormsby, P. J. Cowan, B. A. Cromer, W. J. McKinstry, M. W. Parker, B. F. Murphy, and D. L. Gordon
Human Factor H-Related Protein 5 Has Cofactor Activity, Inhibits C3 Convertase Activity, Binds Heparin and C-Reactive Protein, and Associates with Lipoprotein
J. Immunol., May 15, 2005; 174(10): 6250 - 6256.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Z.-Z. Cheng, M. J. Corey, M. Parepalo, S. Majno, J. Hellwage, P. F. Zipfel, R. J. Kinders, M. Raitanen, S. Meri, and T. S. Jokiranta
Complement Factor H as a Marker for Detection of Bladder Cancer
Clin. Chem., May 1, 2005; 51(5): 856 - 863.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
A. Saito and H. Munakata
Factor H Is a Dermatan Sulfate-Binding Protein: Identification of a Dermatan Sulfate-Mediated Protease That Cleaves Factor H
J. Biochem., February 1, 2005; 137(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. K. Ganesh, S. A. Smith, G. J. Kotwal, and K. H. M. Murthy
Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation
PNAS, June 15, 2004; 101(24): 8924 - 8929.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Alitalo, T. Meri, T. Chen, H. Lankinen, Z.-Z. Cheng, T. S. Jokiranta, I. J. T. Seppala, P. Lahdenne, P. S. Hefty, D. R. Akins, et al.
Lysine-Dependent Multipoint Binding of the Borrelia burgdorferi Virulence Factor Outer Surface Protein E to the C Terminus of Factor H
J. Immunol., May 15, 2004; 172(10): 6195 - 6201.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
L. Kask, B. O. Villoutreix, M. Steen, B. Ramesh, B. Dahlback, and A. M. Blom
Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H
Protein Sci., May 1, 2004; 13(5): 1356 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M.-A. Dragon-Durey, V. Fremeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, G. Deschenes, P. Coppo, W. Herman Fridman, and L. Weiss
Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 787 - 795.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Jarva, J. Hellwage, T. S. Jokiranta, M. J. Lehtinen, P. F. Zipfel, and S. Meri
The Group B Streptococcal {beta} and Pneumococcal Hic Proteins Are Structurally Related Immune Evasion Molecules That Bind the Complement Inhibitor Factor H in an Analogous Fashion
J. Immunol., March 1, 2004; 172(5): 3111 - 3118.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Richards, E. J. Kemp, M. K. Liszewski, J. A. Goodship, A. K. Lampe, R. Decorte, M. H. Muslumanogglu, S. Kavukcu, G. Filler, Y. Pirson, et al.
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome
PNAS, October 28, 2003; 100(22): 12966 - 12971.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Oksjoki, H. Jarva, P. T. Kovanen, P. Laine, S. Meri, and M. O. Pentikainen
Association Between Complement Factor H and Proteoglycans in Early Human Coronary Atherosclerotic Lesions: Implications for Local Regulation of Complement Activation
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Hellwage, T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen, P. F. Zipfel, and S. Meri
Complement C3b/C3d and Cell Surface Polyanions Are Recognized by Overlapping Binding Sites on the Most Carboxyl-Terminal Domain of Complement Factor H
J. Immunol., December 15, 2002; 169(12): 6935 - 6944.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Pangburn
Cutting Edge: Localization of the Host Recognition Functions of Complement Factor H at the Carboxyl-Terminal: Implications for Hemolytic Uremic Syndrome
J. Immunol., November 1, 2002; 169(9): 4702 - 4706.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. G. Duthy, R. J. Ormsby, E. Giannakis, A. D. Ogunniyi, U. H. Stroeher, J. C. Paton, and D. L. Gordon
The Human Complement Regulator Factor H Binds Pneumococcal Surface Protein PspC via Short Consensus Repeats 13 to 15
Infect. Immun., October 1, 2002; 70(10): 5604 - 5611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Areschoug, M. Stalhammar-Carlemalm, I. Karlsson, and G. Lindahl
Streptococcal beta Protein Has Separate Binding Sites for Human Factor H and IgA-Fc
J. Biol. Chem., April 5, 2002; 277(15): 12642 - 12648.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Jarva, R. Janulczyk, J. Hellwage, P. F. Zipfel, L. Bjorck, and S. Meri
Streptococcus pneumoniae Evades Complement Attack and Opsonophagocytosis by Expressing the pspC Locus-Encoded Hic Protein That Binds to Short Consensus Repeats 8-11 of Factor H
J. Immunol., February 15, 2002; 168(4): 1886 - 1894.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. CAPRIOLI, P. BETTINAGLIO, P. F. ZIPFEL, B. AMADEI, E. DAINA, S. GAMBA, C. SKERKA, N. MARZILIANO, G. REMUZZI, and M. NORIS
The Molecular Basis of Familial Hemolytic Uremic Syndrome: Mutation Analysis of Factor H Gene Reveals a Hot Spot in Short Consensus Repeat 20
J. Am. Soc. Nephrol., February 1, 2001; 12(2): 297 - 307.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. A. Smith, N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, et al.
Conserved Surface-Exposed K/R-X-K/R Motifs and Net Positive Charge on Poxvirus Complement Control Proteins Serve as Putative Heparin Binding Sites and Contribute to Inhibition of Molecular Interactions with Human Endothelial Cells: a Novel Mechanism for Evasion of Host Defense
J. Virol., June 15, 2000; 74(12): 5659 - 5666.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Junnikkala, T. S. Jokiranta, M. A. Friese, H. Jarva, P. F. Zipfel, and S. Meri
Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 1
J. Immunol., June 1, 2000; 164(11): 6075 - 6081.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Jarva, T. S. Jokiranta, J. Hellwage, P. F. Zipfel, and S. Meri
Regulation of Complement Activation by C-Reactive Protein: Targeting the Complement Inhibitory Activity of Factor H by an Interaction with Short Consensus Repeat Domains 7 and 8-11
J. Immunol., October 1, 1999; 163(7): 3957 - 3962.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Blom, J. Webb, B. O. Villoutreix, and B. Dahlback
A Cluster of Positively Charged Amino Acids in the C4BP alpha -Chain Is Crucial for C4b Binding and Factor I Cofactor Function
J. Biol. Chem., July 2, 1999; 274(27): 19237 - 19245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri
Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3b
J. Biol. Chem., September 1, 2000; 275(36): 27657 - 27662.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Pio, A. Martinez, E. J. Unsworth, J. A. Kowalak, J. A. Bengoechea, P. F. Zipfel, T. H. Elsasser, and F. Cuttitta
Complement Factor H Is a Serum-binding Protein for Adrenomedullin, and the Resulting Complex Modulates the Bioactivities of Both Partners
J. Biol. Chem., April 6, 2001; 276(15): 12292 - 12300.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.